ERIS LIFESCIENCES
|
The Current P/E Ratio of ERIS LIFESCIENCES is 59.38.
Share Price | ₹1,786.5 | Aug 28,2025 |
Market Cap | ₹24,332.1 Cr | |
Earnings-TTM | ₹409.8 Cr | TTM-Consolidated Results |
Price/Earnings | 59.38x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ERIS LIFESCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹24,332.1 Cr] as on Aug 28,2025
(/) Earnings [ ₹409.8 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 59.38x ]
Thus, for ERIS LIFESCIENCES , the investors are currently willing to pay 59.38 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ERIS LIFESCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ERIS LIFESCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of ERIS LIFESCIENCES
PE Ratio Performance Analysis for ERIS LIFESCIENCES
- ERIS LIFESCIENCES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 30.11x.
- ERIS LIFESCIENCES 's operated at median p/e ratio of 23.11x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ERIS LIFESCIENCES 's p/e ratio peaked in Mar2025 at 54.83x.
- ERIS LIFESCIENCES 's p/e ratio hit its five-year low in Mar2023 of 20.36x.
How does ERIS LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ERIS LIFESCIENCES | 409.78 | 59.38 | 24,332.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 36.56 | 380,594.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 70.56 | 162,722.0 |
CIPLA LTD | 5,406.81 | 23.58 | 127,508.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.50 | 121,111.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.37 | 105,225.0 |
MANKIND PHARMA LTD | 1,905.51 | 53.60 | 102,137.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.20 | 98,299.0 |
LUPIN LTD | 3,722.18 | 23.35 | 86,895.3 |
AUROBINDO PHARMA LTD | 3,417.93 | 17.48 | 59,744.2 |
ABBOTT INDIA LTD | 1,452.29 | 46.08 | 66,915.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ERIS LIFESCIENCES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.48x |
Max industry PE | 70.56x |
Median industry PE | 36.56x |
Average industry PE | 39.15x |
You may also like the below Video Courses